title: Clinical trials of low-molecular-weight heparins in cardiology.
abstract: Our understanding of the pathophysiology of acute coronary syndromes is evolving as the role of prognostic coagulation markers and the different effects unfractionated heparin and low-molecular-weight heparins have on these coagulation markers are investigated. The results of recent clinical trials of low-molecular-weight heparins in acute coronary syndromes are summarized, and an economic evaluation of enoxaparin for these indications is reviewed.
authors.affiliation: Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Pennsylvania 19104, USA.
authors.forename: S A
authors.initials: SA
authors.lastname: Spinler
mesh_terms: D000208:Acute Disease; D015415:Biomarkers / Q000032:analysis; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy* / Q000191:economics; D017984:Enoxaparin / Q000191:economics / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000191:economics / Q000627:therapeutic use*; D006801:Humans
chemical_list: D015415:Biomarkers; D017984:Enoxaparin; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight